9LDR image
Deposition Date 2025-01-06
Release Date 2025-04-23
Last Version Date 2026-05-13
Entry Detail
PDB ID:
9LDR
Title:
Overall structure of the y+LAT2-4F2hc bound with Leu
Biological Source:
Source Organism(s):
Homo sapiens (Taxon ID: 9606)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.58 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Y+L amino acid transporter 2
Gene (Uniprot):SLC7A6
Chain IDs:A
Chain Length:534
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Amino acid transporter heavy
Gene (Uniprot):SLC3A2
Chain IDs:B
Chain Length:645
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural insights into the human system y + L amino acid transporter complex.
Structure 33 1224 1232.e5 (2025)
PMID: 40347950 DOI: 10.1016/j.str.2025.04.012

Abstact

System y(+)L facilitates the sodium-independent transport of cationic and sodium-dependent transport of neutral amino acids via heteromeric amino acid transporters. System y(+)L consists of either SLC7A6 (y(+)LAT2) or SLC7A7 (y(+)LAT1) and 4F2hc (SLC3A2). The y(+)LAT2-4F2hc complex mediates the exchange of (L)-lysine (Lys), (L)-arginine (Arg), (L)-leucine (Leu), and (L)-glutamine (Gln) and is important for the glutamate-glutamine cycle and ammonia clearance. c-Myc-driven upregulation of y(+)LAT2 in cancer enhances amino acid uptake and mTORC1 activation, promoting tumor growth. Its transport mechanism has remained unclear. Here, we determined the cryoelectron microscopic (cryo-EM) structures of the y(+)LAT2-4F2hc complex bound to either Arg or Leu at 3.60 A and 3.58 A resolution, respectively, revealing an outward-open conformation. Our structural analysis highlights conformational changes during transport, and functional assays validate critical residues involved in substrate binding and transport. These findings elucidate the molecular mechanism of the system y(+)L and provide a foundation for developing targeted therapies against y(+)LAT2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback